Publication date: Jul 12, 2023
Fire and rescue services undertook a range of additional activities to support the National Health Service (NHS) in managing extreme service demand during the COVID-19 pandemic. This study aims to examine the cost-benefit of partnership work between fire and rescue services and the NHS during the COVID-19 pandemic. England and Wales. A cost-benefit approach was used. Data relating to resources and outcomes was accessed from a National Data Portal commissioned by the National Fire Chiefs Council to record fire and rescue service responses throughout the pandemic. Literature-based economic estimates were applied to establish the potential cost-benefit of fire and rescue services undertaking support activities. Fire and rescue services commonly undertook eight activities to support ambulance services and hospitals in three key areas: (1) driving ambulances, (2) provision of personal protective equipment for healthcare workers and (3) mass testing and mass vaccination. Benefits outweighed costs for all activities. Total costs were estimated at lb93. 26 million and total benefits were between lb171. 46 million and lb1. 10 billion. This is the first economic evaluation of partnership working between fire and rescue and health services during a pandemic. Findings highlight the social and economic value of co-operation between fire and rescue services and the NHS and provides important evidence for informing public sector decisions regarding the allocation of resources in future public health crises.
Open Access PDF
Concepts | Keywords |
---|---|
10billion | COVID-19 |
Ambulances | Health economics |
Economic | Health policy |
Pandemic |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 pandemic |
disease | VO | vaccination |
disease | MESH | Emergency |
disease | IDO | history |
disease | VO | efficiency |
disease | VO | effectiveness |
drug | DRUGBANK | L-Valine |
drug | DRUGBANK | Coenzyme M |
disease | VO | effective |
disease | IDO | intervention |
drug | DRUGBANK | Etoperidone |
disease | VO | time |
disease | MESH | infection |
disease | VO | vaccine |
disease | VO | vaccine dose |
disease | MESH | uncertainty |
disease | VO | population |
drug | DRUGBANK | Trestolone |
disease | IDO | process |
disease | VO | document |
drug | DRUGBANK | Thiamine |
disease | VO | report |